HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Motoko Yamaguchi Selected Research

Extranodal NK-T-Cell Lymphoma

10/2022Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
1/2018[Treatment of NK/T-cell lymphoma: current situations and prospectives].
8/2012Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
12/2011Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type.
5/2010Pretreatment total serum protein is a significant prognostic factor for the outcome of patients with peripheral T/natural killer-cell lymphomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Motoko Yamaguchi Research Topics

Disease

21Lymphoma (Lymphomas)
03/2022 - 01/2003
13T-Cell Lymphoma (Lymphoma, T Cell)
07/2021 - 01/2003
13Neoplasms (Cancer)
11/2018 - 01/2003
7B-Cell Lymphoma (Lymphoma, B Cell)
01/2021 - 04/2004
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2021 - 08/2002
5Extranodal NK-T-Cell Lymphoma
10/2022 - 05/2010
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2018 - 08/2002
2Disease Progression
06/2018 - 12/2017
2Leukopenia
08/2012 - 04/2010
2Liver Diseases (Liver Disease)
04/2010 - 01/2009
2Thrombocytopenia (Thrombopenia)
04/2010 - 01/2007
2Large Granular Lymphocytic Leukemia
04/2010 - 05/2008
2Disseminated Intravascular Coagulation
01/2006 - 01/2005
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2004 - 01/2003
1Cognitive Dysfunction
07/2021
1Peripheral Nervous System Diseases (PNS Diseases)
05/2020
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2020
1Atypical Hemolytic Uremic Syndrome
01/2018
1Neutropenia
08/2012
1Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2011
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
05/2010
1Multiple Myeloma
04/2009
1Plasmacytoma
04/2009
1Leukemia
05/2008
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
05/2008
1Infections
01/2006
1Thrombosis (Thrombus)
01/2006
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2006
1Neoplasm Metastasis (Metastasis)
03/2005
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2005
1Pleural Empyema (Pyothorax)
04/2004

Drug/Important Bio-Agent (IBA)

10Rituximab (Mabthera)FDA Link
07/2021 - 07/2008
6Methotrexate (Mexate)FDA LinkGeneric
07/2021 - 05/2008
6Vincristine (Oncovin)FDA LinkGeneric
07/2021 - 10/2011
6Etoposide (VP 16)FDA LinkGeneric
12/2020 - 03/2005
5AnthracyclinesIBA
10/2022 - 01/2007
5Doxorubicin (Adriamycin)FDA LinkGeneric
12/2020 - 10/2011
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2020 - 10/2011
4Asparaginase (Elspar)FDA Link
11/2020 - 05/2008
4IfosfamideFDA LinkGeneric
08/2012 - 03/2005
3Prednisone (Sone)FDA LinkGeneric
05/2020 - 10/2011
3Dexamethasone (Maxidex)FDA LinkGeneric
11/2011 - 03/2005
2Prednisolone (Predate)FDA LinkGeneric
12/2020 - 01/2020
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2018 - 10/2011
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2017 - 05/2008
2SteroidsIBA
08/2012 - 11/2011
2DNA (Deoxyribonucleic Acid)IBA
08/2012 - 12/2011
2Proteins (Proteins, Gene)FDA Link
08/2008 - 01/2003
2Thromboplastin (Tissue Factor)IBA
01/2006 - 01/2005
2Messenger RNA (mRNA)IBA
01/2006 - 01/2005
2Dacarbazine (DIC)FDA LinkGeneric
01/2006 - 01/2005
2fibrin fragment D (D-dimer)IBA
01/2006 - 01/2005
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2005 - 08/2002
2Integrin beta1IBA
03/2004 - 01/2003
1polatuzumab vedotinIBA
07/2021
1Bendamustine HydrochlorideFDA Link
07/2021
1Procarbazine (Matulane)FDA Link
07/2021
1Cytochrome P-450 CYP3AIBA
05/2020
1R-CHOP protocolIBA
05/2020
1Dihydrotachysterol (AT 10)IBA
11/2018
1eculizumabFDA Link
01/2018
1Biomarkers (Surrogate Marker)IBA
11/2014
1Indicators and Reagents (Reagents)IBA
12/2011
1purineIBA
02/2011
1CladribineFDA LinkGeneric
02/2011
1AlbuminsIBA
05/2010
1Blood Proteins (Serum Proteins)IBA
05/2010
1HLA-DR Antigens (HLA-DR)IBA
04/2010
1Ferritins (Ferritin)IBA
04/2010
1C-Reactive ProteinIBA
01/2006
1FibrinIBA
01/2006
1Hemostatics (Antihemorrhagics)IBA
01/2006
1Leukocyte Elastase (Neutrophil Elastase)IBA
01/2006
1SHU 508 (Levovist)IBA
01/2006
1Hemoglobins (Hemoglobin)IBA
06/2005
1T-Cell Intracellular Antigen-1IBA
03/2005
1Carboplatin (JM8)FDA LinkGeneric
03/2005
1Thomsen-Friedenreich antigenIBA
01/2005
1Fibrinogen (Factor I)FDA Link
01/2005
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2005
1formycin diphosphate (FDP)IBA
01/2005
1CytokinesIBA
01/2005
1von Willebrand FactorIBA
01/2005
1RNA (Ribonucleic Acid)IBA
04/2004
1AntigensIBA
04/2004
1B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
04/2004
1Cyclin D1IBA
03/2004
1Death-Associated Protein KinasesIBA
01/2003

Therapy/Procedure

15Drug Therapy (Chemotherapy)
11/2020 - 09/2005
14Therapeutics
10/2022 - 04/2004
7Chemoradiotherapy
06/2018 - 11/2009
4Radiotherapy
07/2021 - 03/2005
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
04/2010 - 09/2005
2Transplantation
03/2022 - 07/2021
2Stem Cell Transplantation
07/2021 - 04/2009
1Aftercare (After-Treatment)
11/2018
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2018
1Salvage Therapy
02/2011
1Combination Drug Therapy (Combination Chemotherapy)
03/2005
1Endoscopes
03/2005